Current Liabilities
Accrued Manufacturing Costs
Edwards Lifesciences Accrued Manufacturing Costs decreased by 43.2% to $265.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.0%, from $232.80M to $265.40M. Over 5 years (FY 2020 to FY 2025), Accrued Manufacturing Costs shows an upward trend with a 14.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2016
Last reportedQ1 2026May 6, 2026
Metric ID:
accrued_manufacturing_costsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $262.20M | $325.00M | $319.70M | $221.70M | $256.00M | $250.00M | $268.70M | $225.80M | $312.70M | $340.00M | $316.40M | $237.20M | $288.70M | $312.10M | $358.60M | $232.80M | $352.70M | $437.40M | $467.50M | $265.40M |
| QoQ Change | — | +24.0% | -1.6% | -30.7% | +15.5% | -2.3% | +7.5% | -16.0% | +38.5% | +8.7% | -6.9% | -25.0% | +21.7% | +8.1% | +14.9% | -35.1% | +51.5% | +24.0% | +6.9% | -43.2% |
| YoY Change | — | — | — | — | -2.4% | -23.1% | -16.0% | +1.8% | +22.1% | +36.0% | +17.8% | +5.0% | -7.7% | -8.2% | +13.3% | -1.9% | +22.2% | +40.1% | +30.4% | +14.0% |
Range$221.70M – $467.50M
CAGR+0.3%
Avg YoY Growth+9.0%
Median YoY Growth+9.2%
Accrued Manufacturing Costs at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's accrued manufacturing costs?
- Edwards Lifesciences (EW) reported accrued manufacturing costs of $265.40M in Q1 2026.
- How has Edwards Lifesciences's accrued manufacturing costs changed year-over-year?
- Edwards Lifesciences's accrued manufacturing costs increased by 14.0% year-over-year, from $232.80M to $265.40M.
- What is the long-term trend for Edwards Lifesciences's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Edwards Lifesciences's accrued manufacturing costs has grown at a 14.6% compound annual growth rate (CAGR), from $236.70M to $467.50M.